Erika Kleiderman

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Advance Care Planning

Top Venues

The American journal of bioethics : AJOB

Journal of medical ethics

Journal of community genetics

Accountability in research

This page only lists publications with an associated author ORCID identifier.

Publications

Anne-Marie Laberge, Marie-Christine Roy, Erika Kleiderman, Vardit Ravitsky
Going Back to Basics: What is the Target of Prenatal Screening? The American journal of bioethics : AJOB 23 (3) (2023)
Erika Kleiderman, Vasiliki Nataly Rahimzadeh, Bartha Maria Knoppers, Marie-Christine Roy, Anne-Marie Laberge, Vardit Ravitsky
The Serious Factor in Expanded Prenatal Genetic Testing. The American journal of bioethics : AJOB 22 (2) (2022)
Erika Kleiderman, Minh Thu Nguyen, Bartha Maria Knoppers
Of the Rights and Best Interests of Future Generations. The American journal of bioethics : AJOB 20 (8) (2020)
Erika Kleiderman, Ubaka Ogbogu
Realigning gene editing with clinical research ethics: What the "CRISPR Twins" debacle means for Chinese and international research ethics governance. Accountability in research 26 (4) (2019)
Erika Kleiderman, Ian Norris Kellner Stedman
Human germline genome editing is illegal in Canada, but could it be desirable for some members of the rare disease community? Journal of community genetics 11 (2) (2019)
Erika Kleiderman, Vardit Ravitsky, Bartha Maria Knoppers
'Serious' factor-a relevant starting point for further debate: a response. Journal of medical ethics 46 (2) (2019)
Erika Kleiderman, Vardit Ravitsky, Bartha Maria Knoppers
The 'serious' factor in germline modification. Journal of medical ethics 45 (8) (2019)
Erika Kleiderman, Amy Pack, Pascal Borry, Ma'n Zawati
The author who wasn't there? Fairness and attribution in publications following access to population biobanks. PloS one 13 (3) (2018)
Erika Kleiderman, Audrey Boily, Craig Hasilo, Bartha Maria Knoppers
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials. Stem cell research & therapy 9 (1) (2018)